Dev Labtech Venture Ltd (DEVLAB) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Dev Labtech Venture Ltd on NSE and BSE, with an AI summary of each filing.
Dev Labtech Venture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve To consider and approve ....
Intimation · 06 Nov 2026, 5:30 am
Dev Labtech Venture Schedules Board Meeting for H1 FY27 Results Dev Labtech Venture Limited has scheduled a Board of Directors meeting on 6th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the statement of assets, liabilities, and cash flows for the half year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain shut until 48 hours following the declaration of the financial results.
Notice of EGM of the Company
Extra Ordinary General Meeting · 12 Oct 2026, 11:27 pm
Dev Labtech Venture Proposes ₹17.81 Crore Preferential Issue of Convertible Warrants Dev Labtech Venture Limited issued an EGM notice for 5th Nov'26 to approve increasing its authorized share capital from ₹25.00 crore to ₹31.00 crore and issuing up to 1.37 crore convertible warrants at ₹13 each (face value ₹5, premium ₹8), aggregating ₹17.81 crore. Warrants are convertible within 18 months, with 25% payable upfront. Out of 1.37 crore warrants, promoters/promoter group will receive 1.08 crore and non-promoters 29.08 lakh. Proceeds will fund new land acquisition (₹16.35 crore) and general corporate purposes (₹1.46 crore).
Preferential Issue of Convertible Warrants
Others (Uncategorized) · 08 Oct 2026, 12:38 am
Dev Labtech Venture Approves ₹17.81 Crore Preferential Warrant Issue Dev Labtech Venture's board approved issuing up to 1.37 crore convertible warrants at ₹13 each (face value ₹5, premium ₹8), aggregating ₹17.81 crore on a preferential basis to 7 promoter and non-promoter investors. The warrants have an 18-month tenor and are convertible into equivalent equity shares, taking promoter and non-promoter shareholding to 61.64% and 38.36%, respectively. The board also approved increasing authorized share capital from ₹25 crore to ₹31 crore, subject to shareholder approval at the EGM scheduled for 5th Nov'26 (cut-off date 29th Oct'26).
Issuance of upto 1,37,00,000 Convertible Warrants in to Equity Shares to Promoter/Promoter Group and Non- Promoters of the Company on Preferential basis.
Others (Uncategorized) · 08 Oct 2026, 12:34 am
Dev Labtech Venture Approves ₹17.81 Crore Preferential Warrant Issue and Capital Increase Dev Labtech Venture Limited's board approved issuing up to 1.37 crore convertible warrants on a preferential basis at ₹13 each (₹5 face value plus ₹8 premium), raising ₹17.81 crore from promoters and non-promoters across seven investors. The warrants have an 18-month tenor. Post-conversion, promoter and non-promoter shareholding will stand at 61.64% and 38.36%, respectively. The board also approved increasing authorized share capital from ₹25 crore to ₹31 crore, subject to shareholder approval at an EGM scheduled for 5th Nov'26, with an e-voting cut-off on 29th Oct'26.
Increase in the Authorised Share Capital of the Company and amendment in Capital Clause of the Memorandum of Association: subject to the approval of shareholders at the ensuing Extra Ordinary ....
Others (Uncategorized) · 08 Oct 2026, 12:30 am
Dev Labtech Venture Approves ₹17.81 Cr Preferential Issue of Convertible Warrants Dev Labtech Venture Limited's board approved raising up to ₹17.81 Cr via a preferential issue of up to 1.37 Cr convertible warrants at ₹13 each (face value ₹5, premium ₹8) to promoter and non-promoter groups across 7 investors. Each warrant is convertible into one equity share within 18 months. Post-allotment, promoter and non-promoter shareholding will stand at 61.64% and 38.36%, respectively. The board also approved increasing authorized share capital from ₹25 Cr to ₹31 Cr, subject to shareholder approval at an EGM on 5th Nov'26.
We hereby inform the Stock Exchange that the Board of Directors of the Company in their Meeting held on Wednesday, the 7th October, 2026 at the Office of the Company situated at Plot No. ....
Outcome · 08 Oct 2026, 12:26 am
Dev Labtech Approves ₹17.81 Crore Preferential Convertible Warrant Issue Dev Labtech Venture's board approved issuing up to 1.37 crore convertible warrants at ₹13 each (face value ₹5, premium ₹8), raising ₹17.81 crore on a preferential basis to promoters and non-promoters across 7 investors. The warrants carry an 18-month tenor, convertible 1:1 into equity shares. Post-conversion, promoter and non-promoter shareholding will stand at 61.64% and 38.36%, respectively. The board also approved increasing authorized share capital from ₹25 crore to ₹31 crore, subject to shareholder approval at the EGM scheduled for 5th Nov'26.
Dev Labtech Venture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve 1. To increase authorized ....
Intimation · 03 Oct 2026, 9:42 pm
Dev Labtech Venture Board to Evaluate Preferential Fundraise and Share Capital Increase Dev Labtech Venture Limited's Board of Directors is scheduled to meet on 7th Oct'26 to evaluate proposals for raising funds via the issuance of equity shares or other eligible convertible securities through a preferential allotment, subject to regulatory and shareholder approvals. Additionally, the board will consider increasing the company's authorized share capital. In compliance with insider trading regulations, the trading window for company insiders was closed starting 2nd Oct'26 and will reopen 48 hours after the formal declaration of the board's decisions.
Scrutinizer's Report along with Voting Results of 33rd Annual General Meeting held on 26th September, 2026.
Annual General Meeting · 26 Sept 2026, 11:51 pm
Proceedings of the 33rd Annual General Meeting held on 26th September, 2026.
Annual General Meeting · 26 Sept 2026, 11:44 pm
Intimation pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 - Availing Credit Facilities from HDFC bank.
Others (Uncategorized) · 07 Sept 2026, 8:05 pm
Dev Labtech Venture Secures INR 2.10 Crore Credit Facility from HDFC Bank Dev Labtech Venture Limited executed a Master Facility Agreement with HDFC Bank on 5th Sep'26 to secure a credit facility of INR 210.00 lakh for working capital requirements. The facility is structured as an Overdraft Against Property for Manufacturers (ODAP-MFRS) carrying a floating interest rate of 8.9% per annum. The facility has a 12-month tenure, repayable on demand and subject to annual renewal, secured by residential and commercial properties alongside collateral in personal guarantees, stock, and debtors.
Pursuant to provisions of Regulations 30 and 36(1)(b) of the SEBI Listing Regulations, as may be amended, we wish to inform that the Company has issued letters providing weblink for accessing ....
Annual General Meeting · 01 Sept 2026, 10:56 pm
Annual Report FY 2025-26
Others (Uncategorized) · 01 Sept 2026, 10:42 pm
Pursuant to Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we are pleased to enclose herewith the Notice of 33rd Annual General Meeting of the ....
Annual General Meeting · 01 Sept 2026, 10:37 pm
We hereby inform the Stock Exchange that the Board of Directors of the Company in their Meeting held on Thursday, the 27th August, 2026 at the Office of the Company situated at Plot No. ....
Others (Uncategorized) · 27 Aug 2026, 9:27 pm
Dev Labtech Venture Announces 33rd AGM and Record Date Dev Labtech Venture's board, in its meeting on 27 Aug'26, approved the Directors' Report for the year ended 31 Mar'26. The 33rd Annual General Meeting (AGM) is scheduled for 26 Sep'26 at 01:00 p.m. via video conference. The company has fixed 19 Sep'26 as the cut-off date to determine shareholder eligibility for e-voting. NSDL has been appointed to provide the e-voting platform for the AGM, with RPK & Associates acting as the scrutinizer for the voting process.
We hereby inform the Stock Exchange that the Board of Directors of the Company in their Meeting held on Monday, the 10th August, 2026 at the Office of the Company situated at Plot No. 53 ....
Others (Uncategorized) · 10 Aug 2026, 10:04 pm
Dev Labtech Reverses US Subsidiary Closure, Secures Rs. 2.1 Cr Credit Facility Dev Labtech Venture's board, in its meeting on 10th Aug'26, approved availing credit facilities of Rs. 2.10 crore from HDFC Bank. The board also reversed its earlier decision to strike off its wholly-owned US subsidiary, Dev Labtech Venture Inc. Citing current business needs and strategic expansion plans, the company will now continue its US operations. This reversal is not expected to have a material adverse impact on the company's financials or operations.
Intimation for Appointment of Secretarial Auditor & Internal Auditor of the Company.
Change in Auditor · 30 May 2026, 2:07 am
Dev Labtech FY26 Results Approved; New Auditors Appointed Dev Labtech Venture's board approved audited standalone and consolidated financial results for the half-year and year ended 31 Mar'26. For FY26, consolidated revenue from operations reached ₹16,718.13 lakh, with a profit after tax of ₹956.88 lakh. Standalone FY26 revenue was ₹5,929.78 lakh with a PAT of ₹0.61 lakh. The board also appointed RPK & Associates as Secretarial Auditor and Rajendrasinh Gohil & Co. as Internal Auditor for FY27, effective 29 May'26. The auditor's report contained an unmodified opinion.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are pleased to enclose herewith the following: 1. Audited Standalone ....
Financial Result · 30 May 2026, 2:00 am
Dev Labtech Reports FY26 Results, Announces Bonus Issue and Share Split Dev Labtech Venture reported FY26 standalone net profit of ₹0.61 Lakh, down from ₹129.38 Lakh YoY. Revenue from operations increased 13.1% YoY to ₹5,929.78 Lakh. For H2FY26, the company posted a net loss of ₹33.07 Lakh versus a profit of ₹80.89 Lakh YoY. The Board approved a 1:1 bonus issue and a stock split from ₹10 to ₹5 face value, increasing share capital to 4,74,52,556 equity shares. Auditors issued an unmodified opinion on the results.
Outcome of Board Meeting the following main business: 1)Considered and approved Audited Standalone and Consolidated Financial Statements for the Year ended 31st March, 2026 and Financial ....
Outcome · 30 May 2026, 1:49 am
Dev Labtech FY26 Results Approved; Appoints New Auditors The Board approved audited standalone and consolidated financial results for the year ended 31st Mar'26. For FY26, standalone revenue was ₹5,929.78 Lakh with a Profit After Tax of ₹0.61 Lakh, down from ₹129.38 Lakh YoY. Consolidated FY26 revenue stood at ₹16,718.13 Lakh with a PAT of ₹956.88 Lakh, up from ₹129.38 Lakh YoY. The Board also appointed RPK & Associates as Secretarial Auditor and Rajendrasinh Gohil & Co. as Internal Auditor, both for FY 2026-27, effective 29th May'26.
Dev Labtech Venture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Standalone and ....
Intimation · 29 May 2026, 5:30 am
Dev Labtech Schedules Board Meeting for FY26 Financials Approval Dev Labtech Venture Ltd. has scheduled a Board of Directors meeting on 29th May'26. The agenda includes consideration and approval of the audited standalone and consolidated financial statements for the half-year and full-year ended 31st Mar'26. This also covers the Statement of Assets and Liabilities, Cash Flow Statement, and the Auditor's report. The trading window, closed since 1st Apr'26, will reopen 48 hours after the results are declared.
Allotment of Bonus Equity Shares.
Bonus Issue · 18 May 2026, 4:42 pm
Dev Labtech Venture Allots 1:1 Bonus Shares Dev Labtech Venture's Board of Directors, at its meeting on 18th May'26, approved the allotment of 2,37,26,278 bonus equity shares of Rs. 5 each. The allotment follows a 1:1 ratio for shareholders on the record date of 15th May'26. Following the issue, the company's paid-up equity share capital has doubled to Rs. 23.73 crore from Rs. 11.86 crore, with the total number of equity shares increasing to 4,74,52,556. The new shares rank pari passu with existing shares.
We wish to inform the Stock Exchange that the Board of Directors of the Company, at their Meeting held on Monday, 18th May, 2026, has, inter alia other businesses, considered and approved ....
Outcome · 18 May 2026, 4:39 pm
Dev Labtech Approves 1:1 Bonus Share Allotment Dev Labtech Venture's board, on 18th May'26, approved the allotment of 2,37,26,278 bonus equity shares in a 1:1 ratio. Shareholders on the record date of 15th May'26 received one new fully paid-up share of Rs. 5/- for every one existing share held. Following the allotment, the company's paid-up equity share capital doubled to Rs. 23.73 Cr, comprising 4,74,52,556 equity shares. The newly allotted bonus shares will rank pari passu with existing equity shares in all respects.
Dev Labtech Venture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve the allotment of Bonus ....
Intimation · 12 May 2026, 5:48 pm
Dev Labtech Venture Board to Approve Bonus Share Allotment Dev Labtech Venture Limited (BSE: 543848) has scheduled a Board of Directors meeting for 18th May'26. The primary agenda is to consider and approve the allotment of Bonus Equity Shares, subject to requisite approvals. This action follows Regulation 29 of the SEBI (LODR) Regulations, 2015. The meeting will be held at the company's office in Surat, Gujarat.
Intimation of New ISIN pursuant to sub-Division/Stock Split of Equity Shares of the Company.
Stock Split · 12 May 2026, 4:52 pm
Dev Labtech Announces New ISIN Post 1:2 Stock Split Dev Labtech Venture Limited announced a 1:2 stock split, sub-dividing one equity share with a face value of Rs. 10 into two equity shares with a face value of Rs. 5 each. The record date for the split is set for 15th May'26. Following the subdivision, the company's equity shares will trade under the new ISIN: INEONIJ01025. This action was disclosed to the BSE as per SEBI regulations.
Intimation of Record Date for Sub-division/Split of Equity Shares & Issue of Bonus Shares.
Bonus Issue · 05 May 2026, 7:38 pm
Dev Labtech Sets Record Date for 1:2 Stock Split and 1:1 Bonus Issue Dev Labtech Venture Ltd has fixed 15th May'26 as the record date for two corporate actions. First, the company will sub-divide its equity shares, splitting one share of Rs. 10 face value into two shares of Rs. 5 face value. Following the split, it will issue bonus shares in a 1:1 ratio, meaning one new bonus share for every one existing share held. Both actions apply to fully paid-up shares, effectively resulting in shareholders receiving four Rs. 5 shares for each original Rs. 10 share.
Intimation of In-Principle Approval for Issue and Allotment of Proposed Bonus equity shares to the Shareholders of the Company.
Bonus Issue · 05 May 2026, 7:28 pm
Dev Labtech Receives Approval for 1:1 Bonus Share Issue Dev Labtech Venture Limited has received in-principle approval from the BSE on 05 May'26 for a proposed bonus issue. The company plans to issue up to 2,37,26,278 bonus equity shares with a face value of Rs. 5 each. The approved ratio is one new equity share for every one existing equity share held by shareholders. This corporate action will effectively double the number of outstanding shares, subject to final allotment. The record date for the bonus issue is yet to be announced.